Ignite Creation Date:
2025-12-24 @ 11:05 PM
Ignite Modification Date:
2025-12-31 @ 4:36 PM
Study NCT ID:
NCT00661869
Status:
COMPLETED
Last Update Posted:
2010-08-09
First Post:
2008-04-16
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Outcome Evaluation of Solutions for Wellness and Team Solutions Program in Patients With Severe Mental Illness
Sponsor:
Manhattan Psychiatric Center
Organization:
Study Overview
Official Title:
Outcome Evaluation of Solutions for Wellness and Team Solutions Program in Patients With Severe Mental Illness
Status:
COMPLETED
Status Verified Date:
2010-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
Wellness
Brief Summary:
Obesity is increasing at an alarming rate in patients with schizophrenia, possibly in association with the increased use of atypical antipsychotics. In order to address the weight and metabolic syndrome issues, Manhattan Psychiatric Center (MPC) has implemented the Solutions for Wellness and Team Solutions Program. This program is designed to create a supportive, educational and monitoring environment to stabilize both the psychiatric and medical conditions and to prepare patients for independent management of their psychiatric and physical health condition in the community.
Detailed Description:
The present program is divided into five detailed segments with three progressive levels, that provide a manualized lesson-by-lesson curriculum for implementation on the treatment mall.
* Medication Education
* Symptom recognition and management
* Living Healthy
* Interpersonal Skills
* Discharge Preparation
The program comprised of detailed instructor and patient manuals, specific curriculums and pre- and post-tests to determine acquisition of the learned materials. All modules are imbedded in weekly small group sessions.
* Each of the 5 modules are discussed in groups in weekly morning or afternoon session, Monday through Friday.
* Each module is divided into three 12-week periods for a total of 36 sessions.
* Upon completing 12 weeks at Level 1, each patient moves to Level 2 and then Level 3 for 12 weeks each.
* Each group has two trained instructors.
* Number of patients per group: ≤ 15.
* Sessions are interspersed within the patient's regular treatment mall classes
* Medication Education
* Symptom recognition and management
* Living Healthy
* Interpersonal Skills
* Discharge Preparation
The program comprised of detailed instructor and patient manuals, specific curriculums and pre- and post-tests to determine acquisition of the learned materials. All modules are imbedded in weekly small group sessions.
* Each of the 5 modules are discussed in groups in weekly morning or afternoon session, Monday through Friday.
* Each module is divided into three 12-week periods for a total of 36 sessions.
* Upon completing 12 weeks at Level 1, each patient moves to Level 2 and then Level 3 for 12 weeks each.
* Each group has two trained instructors.
* Number of patients per group: ≤ 15.
* Sessions are interspersed within the patient's regular treatment mall classes
Study Oversight
Has Oversight DMC:
True
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: